Schizophrenia and COVID-19: risks and recommendations

Fonseca, Laís; Diniz, Elton; Mendonça, Guilherme Silva; Malinowski, Fernando; Mari, Jair J.; Gadelha, Ary

doi:10.1590/1516-4446-2020-0010

Cited by 91 publications

(98 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Moreover, infected patients with schizophrenia may have more severe symptoms compared to others. These patients also may be impeded their access to treatment and intervention, rising the risk of relapse (Fonseca et al, 2020). Despite this conditions, patients with severe mental disorders have widely been overlooked (Li and Zhang, 2020).…”

Section: To the Editormentioning

confidence: 99%

“…Not only are medical aspects of this virus important, but also research on the psychiatric factors should be warranted, as it is well known that this virus is highly neurotropic and psychiatric patients, a population at risk. Hence, clinicians and families must keep alert on both physical and psychiatric symptoms, in order to detect the infection in early stages (Fonseca et al, 2020).…”

Section: To the Editormentioning

confidence: 99%

See 1 more Smart Citation

Schizophrenia and COVID-19 delirium

Palomar-Ciria

Valle

Heras

et al. 2020

Psychiatry Research

View full text Add to dashboard Cite

Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre-including this research content-immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

show abstract

Section: To the Editormentioning

confidence: 99%

Section: To the Editormentioning

confidence: 99%

Schizophrenia and COVID-19 delirium

Palomar-Ciria

Valle

Heras

et al. 2020

Psychiatry Research

View full text Add to dashboard Cite

show abstract

“…Concerning performed studies on mental issues, first, Fonseca et al (2020) established recommendations for patients with schizophrenia. Among recommendations are an adequate identification of COVID-19 symptoms, prevention of worsening of psychiatric symptoms, relapses due to the closed environment, fear of disease and isolation, use of telemedicine, promoting adherence to antipsychotic medication regimens, reducing emotional distress, hygiene practices, and family support.…”

Section: Mental Health Considerationsmentioning

confidence: 99%

Contributions of Latin American researchers in the understanding of the novel coronavirus outbreak: a literature review

Fiesco-Sepúlveda

Serrano-Bermúdez

2020

PeerJ

View full text Add to dashboard Cite

This article aimed to give the visibility of Latin American researchers’ contributions to the comprehension of COVID-19; our method was a literature review. Currently, the world is facing a health and socioeconomic crisis caused by the novel coronavirus, SARS-CoV-2, and its disease COVID-19. Therefore, in less than 4 months, researchers have published a significant number of articles related to this novel virus. For instance, a search focused on the Scopus database on 10 April 2020, showed 1,224 documents published by authors with 1,797 affiliations from 80 countries. A total of 25.4%, 24.0% and 12.6% of these national affiliations were from China, Europe and the USA, respectively, making these regions leaders in COVID-19 research. In the case of Latin America, on 10 April 2020, we searched different databases, such as Scopus, PubMed and Web of Science, finding that the contribution of this region was 2.7 ± 0.6% of the total publications found. In other words, we found 153 publications related to COVID-19 with at least one Latin American researcher. We summarized and processed the information from these 153 publications, finding active participation in topics like medical, social and environmental considerations, bioinformatics and epidemiology.

show abstract

“…Among elders and those who have chronic medical conditions, the presence of a positive family and previous history mental disorder, and having poor psychosocial supports were hypothesized either to provoke or exacerbate the existing mental problems during the COVID-19 pandemic. 13,17,18 SARS-CoV-2 has a adverse psychological impact on mental health status of the community, and particularly when associated with psychotic symptoms, it could affect the overall quality-of-life. 19 On the other hand, people with psychotic disorder are also a high risk group for the rapid expansion of COVID-19.…”

Section: Discussionmentioning

confidence: 99%

<p>Available Evidence and Ongoing Hypothesis on Corona Virus (COVID-19) and Psychosis: Is Corona Virus and Psychosis Related? A Narrative Review</p>

Tariku

Hajure²

2020

PRBM

View full text Add to dashboard Cite

Background: Corona virus (COVID-19) is an outbreak of respiratory disease caused by a novel corona virus and declared to be a global health emergency and a pandemic by the World Health Organization (WHO) on March 11, 2020. Prevention strategies to control the transmission of the COVID-19 pandemic, such as closing of schools, refraining from gathering, and social distancing, have direct impacts on mental well-being. SARS-CoV-2 has a devastating psychological impact on the mental health status of the community and, particularly when associated with psychotic symptoms, it could affect the overall quality-of-life. The virus also has the potential to enter and infect the brain. As a result, psychosis symptoms could be an emerging phenomenon associated with the corona virus pandemic. The presence of psychotic symptoms may complicate the management options of patients with COVID-19. Objective: The aim of this article review is to elaborate the relationships between COVID-19 and psychotic symptoms. Methodology: We independently searched different electronic databases, such as Google scholar, PubMed, Medline, CINAHL, EMBASE, PsychInfo, and other relevant sources published in English globally, by using the search terms "psychosis and COVID-19", "corona virus", "brief psychotic", "schizophrenia", "organic psychosis", "infectious disease", "mental illness", "pandemics", and "psychiatry" in various permutations and combinations. Results: The results of the included studies revealed that patients with a novel corona virus had psychotic symptoms, including hallucination in different forms of modality, delusion, disorganized speech, and grossly disorganized or catatonic behaviors. The patients with COVID-19related psychotic symptoms had responded with a short-term administration of the antipsychotic medication. Conclusion and Recommendation: A corona virus-related psychosis has been identified in different nations, but it is difficult to conclude that a novel corona virus has been biologically related to psychosis or exacerbates psychotic symptoms. Therefore, to identify the causal relationships between COVID-19 and psychosis, the researchers should investigate the prospective study on the direct biological impacts of COVID-19 and psychosis, and the clinicians should pay attention for psychotic symptoms at the treatment center and isolation rooms in order to reduce the complication of a novel corona virus.

show abstract

Schizophrenia and COVID-19: risks and recommendations

Cited by 91 publications

References 26 publications

Schizophrenia and COVID-19 delirium

Schizophrenia and COVID-19 delirium

Contributions of Latin American researchers in the understanding of the novel coronavirus outbreak: a literature review

<p>Available Evidence and Ongoing Hypothesis on Corona Virus (COVID-19) and Psychosis: Is Corona Virus and Psychosis Related? A Narrative Review</p>

Contact Info

Product

Resources

About